DMK Pharmaceuticals Total Liabilities

DMK Pharmaceuticals (DMK) currently reports a total liabilities of $12M as of December 2022. That compares with $12M in the prior-year period — down 6.7% year over year. Use the charts on this page to explore DMK Pharmaceuticals's total liabilities history and peer comparisons.

DMK Pharmaceuticals's total liabilities decreased from $12M to $12M — a 6.7% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DMK Pharmaceuticals reported $12M in total liabilities as of December 2022. That compares with $12M in the prior-year period — down 6.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DMK Pharmaceuticals, and consider following DMK for alerts when major investors trade the stock.

DMK Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMK with unrelated industries.